World news, news around town, tech update 3
Ad
Tuesday, 23 May 2017
FDA clears Merck's Keytruda for cancer patients with certain biomarkers
(Reuters) - The U.S. Food and Drug Administration on Tuesday approved Merck & Co's immuno-oncology treatment, Keytruda, for cancer patients who carry a specific genetic feature.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment